We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
It’s almost flu season and, if you’re a twice-monthly plasma donor, CSL Plasma has your vaccination covered.
To stay well, experts recommend both a flu shot and a new, revamped vaccine against COVID-19.
Early research shows the potential of sa-mRNA “as the next generation of influenza vaccine technology,” says Roberta Duncan, …
University of Illinois’ Nicholas Wu wins Seqirus-supported award for vaccine research.
Health officials recommend getting vaccinated against seasonal influenza, but do you know why? For one thing, the flu is alwa…
CSL Behring offers an influenza vaccine clinic for employees and their families.
Should you get both vaccinations? Yes, says an infectious disease doctor with the U.S. National Foundation for Infectious Dis…
Plasma donors can get a voucher for a flu shot and, yes, you can donate plasma after receiving the flu vaccine.
Lorna Meldrum, a leader at flu vaccine provider Seqirus, talks about the twin threats of COVID-19 and seasonal flu on a new p…
Innovation is step one with vaccines. Then you have to get the vaccine into syringes and out the door so it can be administer…
On a new episode of World of Promise, an R&D leader discusses vaccine innovation, including aQIVc and self-amplifying mRNA.
See what Beverly Taylor, a leader at one of the world’s largest flu vaccine providers, Seqirus, said about the upcoming flu s…
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
